Business Segments · Goodwill
Life Sciences and Diagnostics Markets — Goodwill
Agilent Technologies Life Sciences and Diagnostics Markets — Goodwill increased by 0.0% to $3.00B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from $2.96B to $3.00B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2023
Last reportedQ4 2025
Rolls up toGoodwill
How to read this metric
An increase reflects recent strategic acquisitions, while a decrease may indicate impairment charges or write-downs due to underperforming acquired assets.
Detailed definition
This represents the intangible asset value recorded when the company acquires another business for a price exceeding the...
Peer comparison
Common in industries with frequent M&A activity, such as biotechnology and medical device manufacturing.
Metric ID:
a_segment_life_sciences_and_diagnostics_markets_goodwillHistorical Data
7 periods
| Q3 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $2.49B | $3.00B | $2.96B | $3.00B | $3.00B | $3.00B | $3.00B |
| QoQ Change | — | +20.5% | -1.3% | +1.3% | -0.0% | -0.1% | +0.0% |
| YoY Change | — | +20.5% | — | — | — | -0.1% | +1.2% |
Range$2.49B – $3.00B
CAGR+13.2%
Avg YoY Growth+7.2%
Median YoY Growth+1.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's life sciences and diagnostics markets — goodwill?
- Agilent Technologies (A) reported life sciences and diagnostics markets — goodwill of $3.00B in Q4 2025.
- How has Agilent Technologies's life sciences and diagnostics markets — goodwill changed year-over-year?
- Agilent Technologies's life sciences and diagnostics markets — goodwill increased by 1.2% year-over-year, from $2.96B to $3.00B.
- What does life sciences and diagnostics markets — goodwill mean?
- The value of intangible assets acquired through business purchases that exceeds the fair value of the acquired company's net assets.